Effect of somatostatin on the growth of gastrointestinal mucosa and pancreas in rats. Role of endogenous gastrin
- PMID: 2446962
- PMCID: PMC1434570
- DOI: 10.1136/gut.28.suppl.227
Effect of somatostatin on the growth of gastrointestinal mucosa and pancreas in rats. Role of endogenous gastrin
Abstract
This study was undertaken to determine the influence of somatostatin on the growth of gastric, duodenal, and pancreatic tissue in rats placed on liquid diet. In the first part of the study animals were fed an elemental liquid diet for 10 days and then killed, and the growth of the oxyntic gland area of the stomach, 2 cm segments of duodenum and pancreatic tissue was determined. Feeding an elemental diet caused a decrease in organ weight, nucleic acid contents and serum gastrin level. Subsequent addition of pentagastrin prevented this reduction in organ weight and RNA and DNA contents while somatostatin failed to affect the decrease in growth parameters or serum gastrin level in tests with or without addition of pentagastrin. In a second part of the study, sham operated and antrectomised rats were used. Antrectomy caused a significant decrease in serum gastrin concentration and resulted in a significant reduction in the weight and RNA and DNA contents of the tissue tested. As in liquid diet, subsequent administration of pentagastrin prevented the reduction in the growth parameters both in tests with and without somatostatin. These results suggest that somatostatin inhibits the growth of the gastroduodenal mucosa by a mechanism involving, at least in part, the suppression of gastrin release.
Similar articles
-
Role of gastrin and cholecystokinin in the growth-promoting action of bombesin on the gastroduodenal mucosa and the pancreas.Regul Pept. 1990 Mar 5;27(3):343-54. doi: 10.1016/0167-0115(90)90123-e. Regul Pept. 1990. PMID: 1691518
-
Growth of pancreas and gastrointestinal mucosa in antrectomized and gastrin-treated rats.Endocrinology. 1979 Sep;105(3):769-73. doi: 10.1210/endo-105-3-769. Endocrinology. 1979. PMID: 467334
-
Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.Gastroenterology. 1976 Jan;70(1):59-65. Gastroenterology. 1976. PMID: 1245285
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Endogenous somatostatin and the gut.Gut. 1986 Apr;27(4):457-67. doi: 10.1136/gut.27.4.457. Gut. 1986. PMID: 2870009 Free PMC article. Review. No abstract available.
Cited by
-
The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer.Br J Cancer. 1991 Jun;63(6):971-4. doi: 10.1038/bjc.1991.212. Br J Cancer. 1991. PMID: 2069853 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials